Clinical Trial Update: Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pyronaridine-artesunate (3:1) to mefloquine-artesunate in falciparum malaria has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Pyronaridine-artesunate (pyronaridine/artesunate)
• mefloquine-artesunate (mefloquine-artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Falciparum Malaria | Phase 3 | Status: COMPLETED | Results posted: 2021-09-17